G544-1735 Screening compound: ethyl 3-({[3-ethyl-6-(3-methoxyphenyl)-1-phenyl-1,4-dihydropyrazolo[4,3-f]pyrrolo[1,2-a][1,4]diazepin-5(6H)-yl]carbonyl}amino)propanoate

G544-1735 Screening compound: ethyl 3-({[3-ethyl-6-(3-methoxyphenyl)-1-phenyl-1,4-dihydropyrazolo[4,3-f]pyrrolo[1,2-a][1,4]diazepin-5(6H)-yl]carbonyl}amino)propanoate
G544-1735 Screening compound: ethyl 3-({[3-ethyl-6-(3-methoxyphenyl)-1-phenyl-1,4-dihydropyrazolo[4,3-f]pyrrolo[1,2-a][1,4]diazepin-5(6H)-yl]carbonyl}amino)propanoate alternative view

Chemical Structure Depiction of ChemDiv screening compound G544-1735
ethyl 3-({[3-ethyl-6-(3-methoxyphenyl)-1-phenyl-1,4-dihydropyrazolo[4,3-f]pyrrolo[1,2-a][1,4]diazepin-5(6H)-yl]carbonyl}amino)propanoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G544-1735

Molecular Formula

C30H33N5O4 (C30 H33 N5 O4)

Compound Name

ethyl 3-({[3-ethyl-6-(3-methoxyphenyl)-1-phenyl-1,4-dihydropyrazolo[4,3-f]pyrrolo[1,2-a][1,4]diazepin-5(6H)-yl]carbonyl}amino)propanoate

IUPAC name

ethyl 3-{[5-ethyl-9-(3-methoxyphenyl)-3-phenyl-1348-tetraazatricyclo[8.3.0.0^{26}]trideca-2(6)41012-tetraene-8-carbonyl]amino}propanoate

SMILES

CCc(c(CN(C1c2cc(OC)ccc2)C(NCCC(OCC)=O)=O)c2-n3c1ccc3)nn2-c1ccccc1

InChI

InChI=1S/C30H33N5O4/c1-4-25-24-20-34(30(37)31-17-16-27(36)39-5-2)28(21-11-9-14-23(19-21)38-3)26-15-10-18-33(26)29(24)35(32-25)22-12-7-6-8-13-22/h6-15,18-19,28H,4-5,16-17,20H2,1-3H3,(H,31,37)/t28-/m1/s1

InChI Key

JIULMRQXLHRPGI-MUUNZHRXSA-N

MDL Number (MFCD)

MFCD27143696

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

527.62

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

5.534

Distribution Coefficient, logD

5.534

Water Solubility, LogSw

-5.36

Polar Surface Area

70.822

Acid Dissociation Constant (pKa)

17.43

Base Dissociation Constant (pKb)

2.44

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

30.00

G544-1735 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Developmental Pathway (Hh/Wnt) Set (2238 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Peptidomimetic Library (37031 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Others
Structure:
  • Mimetics
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with G544-1735 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G544-1735?
Check Price and Availability of G544-1735, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G544-1735 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G544-1735
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G544-1735
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G544-1735 available by request